Evidence map›Paper›PMID 39932797›Full record

ArticleJCI insight2025

Short-term disruption of TGF-β signaling in adult mice renders the aorta vulnerable to hypertension-induced dissection.

Bo Jiang, Pengwei Ren, Changshun He, Mo Wang, Sae-Il Murtada, María Jesús Ruiz-Rodríguez, Yu Chen, Abhay B Ramachandra, Guangxin Li, Lingfeng Qin and 4 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Hypertension drives thoracic aortic aneurysm and dissection in male, but not female, Marfan mice.Journal of the mechanical behavior of biomedical materials · 2026
    Article
  2. Mechanics and mechanobiology of arterial development.Biomechanics and modeling in mechanobiology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Transforming growth factor-beta (TGF-β) in the pathogenesis of hereditary thoracic aneurysm disorders.Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Bo JiangDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Pengwei RenDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Changshun HeDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Mo WangDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Sae-Il MurtadaDepartment of Biomedical Engineering, Yale School of Engineering and Applied Science, New Haven, Connecticut, USA.
María Jesús Ruiz-RodríguezDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Yu ChenDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Abhay B RamachandraDepartment of Biomedical Engineering, Yale School of Engineering and Applied Science, New Haven, Connecticut, USA.
Guangxin LiDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Lingfeng QinDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Roland AssiDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.
Martin A SchwartzDepartment of Biomedical Engineering, Yale School of Engineering and Applied Science, New Haven, Connecticut, USA.
Jay D HumphreyDepartment of Biomedical Engineering, Yale School of Engineering and Applied Science, New Haven, Connecticut, USA.
George TellidesDepartment of Surgery (Cardiac), Yale School of Medicine, New Haven, Connecticut, USA.

Funding

TGFb-Dependent Cell-Matrix Interactions in Thoracic AortopathyP01HL169168 · NHLBI · YALE UNIVERSITY · PI Jay D. Humphrey · 2025 to 2026
$7.4M
Vascular smooth muscle cell heterogeneity and diseaseR01HL152197 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL, TELLIDES, GEORGE · 2021 to 2024
$3.3M
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and DissectionR01HL146723 · NHLBI · YALE UNIVERSITY · PI HUMPHREY, JAY D., TELLIDES, GEORGE · 2019 to 2022
$2.9M
NHLBI NIH HHS P01 HL169168NHLBI NIH HHS R01 HL146723NHLBI NIH HHS R01 HL152197
6 · The paper itself

Abstract

Hypertension and transient increases in blood pressure from extreme exertion are risk factors for aortic dissection in patients with age-related vascular degeneration or inherited connective tissue disorders. Yet, a common experimental model of angiotensin II-induced aortopathy in mice appears independent of high blood pressure, as lesions do not occur in response to an alternative vasoconstrictor, norepinephrine, and are not prevented by cotreatment with a vasodilator, hydralazine. We investigated vasoconstrictor administration to adult mice following 1 week of disrupted TGF-β signaling in smooth muscle cells (SMCs). Norepinephrine increased blood pressure and induced aortic dissection by 7 days and even within 30 minutes (as did angiotensin II) that was prevented by hydralazine. Initial medial injury manifested as blood extravasation among SMCs and fibrillar matrix, progressive delamination from accumulation of blood, and stretched or ruptured SMCs with persistent attachments to elastic fibers. Altered regulatory contractile molecule expression was not of pathological importance. Rather, reduced synthesis of extracellular matrix yielded a vulnerable aortic phenotype by decreasing medial collagen, most dynamically basement membrane-associated multiplexin collagen, and impairing cell-matrix adhesion. We conclude that transient and sustained increases in blood pressure can cause dissection in aortas rendered vulnerable by inhibition of TGF-β-driven extracellular matrix production by SMCs.

Indexed as

AortaAortic DissectionHypertensionTransforming Growth Factor betaAngiotensin IIAnimalsBlood PressureDisease Models, AnimalExtracellular MatrixHydralazineMaleMiceMice, Inbred C57BLMuscle, Smooth, VascularMyocytes, Smooth MuscleNorepinephrineAngiotensin IIHydralazineNorepinephrineTransforming Growth Factor betaVasoconstrictor AgentsCardiovascular diseaseCell biologyExtracellular matrixHypertensionVascular biology

Identifiers

PMID39932797
PMCPMC11949005

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.